1. Home
  2. UK vs HEPA Comparison

UK vs HEPA Comparison

Compare UK & HEPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UK
  • HEPA
  • Stock Information
  • Founded
  • UK 2015
  • HEPA 2013
  • Country
  • UK China
  • HEPA United States
  • Employees
  • UK N/A
  • HEPA N/A
  • Industry
  • UK Business Services
  • HEPA Biotechnology: Pharmaceutical Preparations
  • Sector
  • UK Consumer Discretionary
  • HEPA Health Care
  • Exchange
  • UK Nasdaq
  • HEPA Nasdaq
  • Market Cap
  • UK 2.3M
  • HEPA 463.4K
  • IPO Year
  • UK N/A
  • HEPA N/A
  • Fundamental
  • Price
  • UK $1.13
  • HEPA $0.39
  • Analyst Decision
  • UK
  • HEPA
  • Analyst Count
  • UK 0
  • HEPA 0
  • Target Price
  • UK N/A
  • HEPA N/A
  • AVG Volume (30 Days)
  • UK 14.8K
  • HEPA 4.6M
  • Earning Date
  • UK 05-20-2025
  • HEPA 05-20-2025
  • Dividend Yield
  • UK N/A
  • HEPA N/A
  • EPS Growth
  • UK N/A
  • HEPA N/A
  • EPS
  • UK N/A
  • HEPA N/A
  • Revenue
  • UK $23,924,045.00
  • HEPA N/A
  • Revenue This Year
  • UK N/A
  • HEPA N/A
  • Revenue Next Year
  • UK N/A
  • HEPA N/A
  • P/E Ratio
  • UK N/A
  • HEPA N/A
  • Revenue Growth
  • UK N/A
  • HEPA N/A
  • 52 Week Low
  • UK $1.00
  • HEPA $0.25
  • 52 Week High
  • UK $2.60
  • HEPA $70.00
  • Technical
  • Relative Strength Index (RSI)
  • UK 54.35
  • HEPA 29.53
  • Support Level
  • UK $1.05
  • HEPA $0.27
  • Resistance Level
  • UK $1.17
  • HEPA $0.49
  • Average True Range (ATR)
  • UK 0.05
  • HEPA 0.06
  • MACD
  • UK 0.00
  • HEPA 0.16
  • Stochastic Oscillator
  • UK 66.75
  • HEPA 60.00

About UK Ucommune International Ltd

Ucommune International Ltd is a flexible office space provider and manager based in the People's Republic of China (PRC). The company offers long-term leasing, on-demand, and short-term leasing solutions to freelancers, start-up entrepreneurs, small and medium enterprises, and corporations. They provide fully-serviced and well-furnished office spaces on a flexible basis. The members of the Ucommune community, which includes individuals and enterprises registered on the U bazaar mobile app, can avail of these services. The company has three operating segments: Workspace membership, Marketing and branding services, and Other services. Marketing and branding services generate the majority of the company's revenue.

About HEPA Hepion Pharmaceuticals Inc.

Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, Rencofilstat, is being developed to offer benefits to address these multiple complex pathologies. Rencofilstat is a pan-cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease.

Share on Social Networks: